Orally Active Amino Acid Mixture Fast Tracked for NASH With Liver Fibrosis
MPR,
The Food and Drug Administration (FDA) has granted Fast Track designation to AXA1125 for the treatment of nonalcoholic…
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
Overview of attention for article published in American Journal of Gastroenterology, August 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (83rd percentile)
Mentioned by
- news
- 1 news outlet
- 35 X users
- patent
- 1 patent
- 2 Facebook pages
- wikipedia
- 2 Wikipedia pages
- 2 Redditors
Readers on
- mendeley
- 59 Mendeley